No Data
No Data
New Journey Health Technology GroupLTD (SZSE:002219) Seems To Use Debt Quite Sensibly
New Journey Health Technology Group (002219.SZ): plans to indirectly acquire 60% equity of Dongying Old Age Hospital.
On December 24, GF Securities reported that New Journey Health Technology Group (002219.SZ) announced that it has signed a "Framework Agreement for the Acquisition of Dongying New Journey Elderly Hospital Co., Ltd." with Peking New Journey Health Industry Group Co., Ltd. (referred to as "New Journey Health"). The company plans to indirectly acquire 60% of the equity in Dongying New Journey Elderly Hospital Co., Ltd. (referred to as "Dongying Elderly Hospital").
TGA Annual Best Action Game Award! "Black Myth: Wukong" sets a new milestone for Chinese gaming.
① On December 13, China's first 3A game "Black Myth: Wukong" won TGA's "Game of the Year" award and the "Players' Voice Award"; ② The game, developed by Game Science, is inspired by "Journey to the West" and has received widespread praise for its graphics, combat system, and storytelling; ③ "Black Myth" was nominated for four awards at TGA and won the 2024 Golden Joystick Award for "Game of the Year" among other awards.
New Journey Health Technology Group (002219.SZ) subsidiary plans to establish a partnership to acquire 100% equity of Chongqing New Journey.
New Journey Health Technology Group (002219.SZ) issued an announcement to better strengthen the company's influence in existing Business areas, improve...
New Journey Health Technology Group (002219.SZ): plans to participate in the establishment of the Qingdao New Journey Medical Industry Investment Center.
On December 11, Glonghui reported that New Journey Health Technology Group Co., Ltd. (hereinafter referred to as the "Company" or "New Journey") announced that in order to better strengthen its influence in existing Business areas, enhance its development and strategic capabilities in Medical Services, optimize the Company's capital structure, and increase its overall competitiveness, the Company convened the 31st meeting of the 6th Board of Directors on December 10, 2024, to review and approve the "Proposal for External Investment," agreeing that the Company's wholly-owned subsidiary, SiChuan Fuhui Pharmaceutical Co., Ltd. (hereinafter referred to as "Fuhui Pharmaceutical"), SiChuan Yongdao Medical.
New journey health technology group milestone! This year, bond issuance in Europe reached 1.705 trillion euros, breaking the previous record of the pandemic peak.
This year, the bond issuance in Europe reached a record high of 1.705 trillion euros (1.8 trillion dollars), surpassing the previous highest level set in 2020.